| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |